Börsenkameraden GROUPE ATHENA aaaaaaaa e.V.

Kosmonova buran

Datum Erster Hoch Tief Schluss     Stücke Volumen
  25.03.15     0,137     0,137§0,137 0,137 $ 445.000 61 T

GrB

...Schrott, wie immer bei den "Experten"-Tipps eines gewissen B.

Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes. http://www.ariva.de/news/...trong-Revenue-And-Earnings-Growth-4493589

facility in India that currently employs 17 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com http://www.ariva.de/news/...trong-Revenue-And-Earnings-Growth-4493589

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets. http://www.ariva.de/news/...trong-Revenue-And-Earnings-Growth-4493589

buran

21:32 26.03.15

NEW YORK (dpa-AFX) - Die US-Börsen haben am Donnerstag ihre Verluste im Handelsverlauf teilweise wieder abgeschüttelt. Angesichts der kräftigen Verluste im Technologiesektor am Vortag hätten Anleger wieder Kaufgelegenheiten gewittert, begründete ein Marktanalyst die im späteren Verlauf erfolgte Erholung. http://www.ariva.de/news/...ew-York-Schluss-Moderate-Verluste-5322267

minus 0,23 Prozent bei 17 678,23 Punkten. Zum Handelsbeginn war er noch wegen der Eskalation im Jemen bis auf 17 579, 27 Zähler gefallen. Der breiter angelegte S&P-500-Index verlor zum Schluss noch 0,24 Prozent auf 2056,15 Punkte. An der technologielastigen Börse Nasdaq sank der Auswahlindex Nasdaq 100 (Nasdaq 100) um 0,32 Prozent auf 4315,26 Zähler. http://www.ariva.de/news/...ew-York-Schluss-Moderate-Verluste-5322267

buran

http://www.ariva.de/articles/hilfe.m GrB

Aktien New York: Moderate Klettertour mit Aussetzern
19:17 27.03.15 http://www.ariva.de/news/...derate-Klettertour-mit-Aussetzern-5323449

has been serving companies abroad in obtaining FDA approval for pharmaceuticals, medical products and devices for export to America. Our goal is to ensure each of our clients passes FDA inspection by assisting them from concept through development, with consultation through all the regulatory requirements, filings, and processes to achieve FDA compliance and approval. groupeathena.com/

consultants of Groupe Athena are in position to go to target companies in Asia and the regulatory authorities in the USA directly, consulting with our clients in the East to serve them completely in providing consultancy services for FDA compliance. Services include providing technical and regulatory consulting for biotechnical products, pharmaceuticals [over the counter, prescription and generics], diagnostics, medical equipment, and devices. groupeathena.com/

complicated, especially for foreign drug and medical companies trying to export to the USA. With broad spectrum consultancy and assistance through this process, our client base can count on reduced risk, follow-through on steps necessary for FDA compliance and identifying and solving breaches in compliance. groupeathena.com/

Athena navigates companies through every requirement of the process including pharmaceutical consulting, development, and regulatory compliance to achieve FDA approval and export pharmaceuticals and medical products and equipment to the USA. groupeathena.com/

buran & MARIO www.facebook.com/mario.meierhof/

:::::::::::::: 0,165 $ +3,13% +0,005 $
In Euro: 0,1503 € | Nasdaq OTC Other, 23.07.15 ,GrB

Datum Erster Hoch Tief Schluss Stücke Volumen
  16.02.16      0,14      0,14§0,14 0,14 $ 5.000 700

GrB

::::::::::: 0,12 $ +20,00% +0,02 $
In Euro: 0,1066 € | 19.04.16 Nasdaq OTC Other ,GrB

For Our Financials, please go to the following link: www.otcmarkets.com/stock/GATA/filings groupeathena.com/investors/

:::::::::::::::: 0,07 $ 0,00% +0,00 $
In Euro: 0,0595 € | 21.08.17 Nasdaq OTC Other ,GrB

groupeathena.com/ GrB